Related Experiment Video
Updated: Mar 2, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
A multifunctional β-cyclodextrin-conjugate photodelivering nitric oxide with fluorescence reporting
Gábor Benkovics1, Marta Perez-Lloret2, Damien Afonso2
1CycloLab, Cyclodextrin R&D Ltd, Illatos út 7, H-1097 Budapest, Hungary; Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Hlavová 8, 128 43 Prague 2, Czech Republic.
This study introduces a novel water-soluble beta-cyclodextrin (βCD) conjugate that releases nitric oxide (NO) and singlet oxygen (1O2) upon visible light excitation, acting as a potential therapeutic agent.
Area of Science:
- Supramolecular Chemistry
- Photochemistry
- Bioconjugation
Background:
- Beta-cyclodextrin (βCD) is a cyclic oligosaccharide with a hydrophobic cavity and hydrophilic exterior, useful for drug delivery.
- Nitric oxide (NO) and singlet oxygen (1O2) are reactive oxygen species with significant therapeutic potential in anticancer and antibacterial applications.
- Developing smart drug delivery systems that can controllably release therapeutic agents upon external stimuli is a key area in nanomedicine.
Purpose of the Study:
- To design and synthesize a novel water-soluble βCD conjugate incorporating anthracene and nitroaniline moieties.
- To investigate the photochemical properties of the conjugate, focusing on photoinduced energy transfer and the release of NO and 1O2.
- To evaluate the potential of the conjugate as a multimodal therapeutic agent for biopharmaceutical research.
Main Methods:
- Synthesis of a cationic, water-soluble βCD conjugate featuring anthracene and nitroaniline.
- Photochemical characterization involving photoinduced energy transfer studies.
- Spectroscopic analysis to monitor NO release and anthracene fluorescence revival.
- Investigation of singlet oxygen generation.
- Guest-binding studies using naphthalene as a model compound.
Main Results:
- The synthesized βCD conjugate demonstrated efficient photoinduced energy transfer, quenching anthracene fluorescence.
- Visible light excitation triggered NO release from the nitroaniline moiety, restoring anthracene fluorescence as an optical reporter.
- The conjugate sequentially photogenerated singlet oxygen (1O2) after NO release.
- The βCD cavity successfully accommodated hydrophobic guests like naphthalene.
- The conjugate showed potential for controlled release of therapeutic agents.
Conclusions:
- The novel βCD conjugate is a promising platform for photodynamic therapy and nitric oxide-based therapies.
- The integrated anthracene moiety serves as an effective optical reporter for NO release.
- The conjugate's ability to generate both NO and 1O2 suggests potential for multimodal therapeutic applications.
- This water-soluble βCD derivative warrants further investigation in biopharmaceutical research for treating cancer and bacterial infections.
More Related Videos
10:55Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
Published on: January 5, 2015
12:51A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles
Published on: November 14, 2015